Detalles de la búsqueda
1.
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England.
BMC Infect Dis
; 24(1): 428, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649824
2.
Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19.
Qual Life Res
; 32(6): 1645-1657, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36703019
3.
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).
Clin Drug Investig
; 44(3): 183-198, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38379107
4.
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study.
BMJ Open Respir Res
; 11(1)2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38575338
5.
Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19.
J Patient Rep Outcomes
; 7(1): 92, 2023 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37702920
Resultados
1 -
5
de 5
1
Próxima >
>>